Company Filing History:
2 out of 20 
2 out of 92 
1 out of 22 
Years Active: 2019-2023
Title: The Innovative Mind of Jinqiu Wang in Pharmaceutical Science
Introduction
Jinqiu Wang, a prominent inventor based in Suzhou, China, has made significant contributions to the field of pharmaceutical science. With a strong portfolio of five patents, his work primarily focuses on advancements in the treatment of anemia through innovative compounds.
Latest Patents
Among his latest patents are notable innovations concerning the crystalline forms of GSK1278863. These patents detail the preparation methods and pharmaceutical applications of crystalline forms CS1 and CS9 of a hypoxia-inducible factor prolyl hydroxylase inhibitor compound known as GSK1278863. These crystalline forms are vital for developing drugs aimed at treating and preventing anemia, showcasing Wang's dedication to improving patient care through pharmaceutical innovation.
Career Highlights
Throughout his career, Jinqiu Wang has worked with esteemed organizations such as Crystal Pharmaceutical (Suzhou) Co., Ltd., and GlaxoSmithKline Intellectual Property (No.2) Limited. His professional experience at these companies has greatly influenced his inventive pursuits, allowing him to translate research into practical health solutions.
Collaborations
Jinqiu has collaborated with other skilled professionals in the field, including Minhua Chen and Yanfeng Zhang. These partnerships have fostered an environment of teamwork and innovation, leading to the successful development of groundbreaking patents in the pharmaceutical sector.
Conclusion
Jinqiu Wang's contributions to the realm of pharmaceutical innovations, particularly his work on GSK1278863, underline his role as a leading inventor in addressing critical health issues. His dedication and collaborative efforts with esteemed colleagues reaffirm the importance of innovation in the ongoing battle against anemia and other health challenges.